# HK inno.N Corporation

Organization · id `cardio:org-hk-inno-n-corporation` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=HK+inno.N+Corporation>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: HK inno.N Corporation
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Phase IV Study to Compare Efficacy and Safety of Plavix 75mg With Astrix 100mg and Closone (`cardio:ct-nct01765452`)
- Sponsors: A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension (`cardio:ct-nct02059616`)
- Sponsors: A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy (`cardio:ct-nct02368652`)
- Sponsors: A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy (`cardio:ct-nct02368665`)
- Sponsors: Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan (`cardio:ct-nct03231982`)
- Sponsors: Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia (`cardio:ct-nct03639480`)
- Sponsors: Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets (`cardio:ct-nct03847506`)
- Sponsors: A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH) (`cardio:ct-nct06627322`)
- Sponsors: Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone (`cardio:ct-nct07308184`)
- Sponsors: Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) (`cardio:ct-nct07687706`)

## Provenance

Content hash: 488a7d8c653df3b08335199b03ed3e3019ea4c649032959c5697cd5e17e10e82
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
